M&A Deal Summary

New Mountain Capital Acquires PerkinElmer

On August 1, 2022, private equity firm New Mountain Capital acquired medical products company PerkinElmer from Revvity for 2.5B USD

Acquisition Highlights
  • This is New Mountain Capital’s 4th transaction in the Medical Products sector.
  • This is New Mountain Capital’s 2nd largest (disclosed) transaction.
  • This is New Mountain Capital’s 82nd transaction in the United States.
  • This is New Mountain Capital’s 4th transaction in Connecticut.

M&A Deal Summary

Date 2022-08-01
Target PerkinElmer
Sector Medical Products
Buyer(s) New Mountain Capital
Sellers(s) Revvity
Deal Type Divestiture
Deal Value 2.5B USD

Target

PerkinElmer

Shelton, Connecticut, United States
PerkinElmer is a global analytics services and solutions provider for the biopharma, food, environmental, safety and applied end markets. The Company offers a comprehensive portfolio of atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables, and reagents, as well as laboratory services through the leading OneSource platform. PerkinElmer is based in Shelton, Connecticut.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

New Mountain Capital

New York, New York, United States

Category Private Equity Firm
Founded 2000
PE ASSETS 35.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

New Mountain Capital is a private investment firm focused on investment in public and private companies in a variety of industries. New Mountain generally invests $100 to $500 million per transaction and looks for businesses with strong market positions and high barriers to entry. New Mountain also prefers businesses that succeed in both good and bad economies. Sectors of interest include education, healthcare, business services, federal IT services, media, software, consumer products, logistics, financial services and technologies, and energy. New Mountain Capital was formed in 2000 and is based in New York City.


DEAL STATS #
Overall 86 of 95
Sector (Medical Products) 4 of 4
Type (Divestiture) 5 of 6
State (Connecticut) 4 of 4
Country (United States) 82 of 90
Year (2022) 6 of 7
Size (of disclosed) 2 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-20 Radancy

New York, New York, United States

Radancy is a recruitment advertising agency with a unified platform, augmented by rich data and deep industry expertise, which is revolutionizing how employers attract and hire the talent they need. Radancy was founded in 1967 and is based in New York City.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-08-16 ClaimLogiq

Mount Pleasant, South Carolina, United States

ClaimLogiq is a healthcare software and technology company that delivers a proactive approach to payment integrity through a powerful, simplified solution. The unique payer-facing, claim-analyzing solution is HITRUST CSF® certified and makes claim reviews accessible to all size healthcare payers for in-depth insight and real-time access into the status of every claim at every stage of the audit lifecycle for controlled, consistent, accurate, and defensible outcomes. ClaimLogiq is based in Mount Pleasant, South Carolina.

Buy -

Seller(S) 1

SELLER

Revvity

Waltham, Massachusetts, United States

Category Company
Founded 1937
Sector Medical Products
Employees11,000
Revenue 2.8B USD (2023)
DESCRIPTION

Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity was formerly known as PerkinElmer. The Company was formed in 1937 and is based in Waltham, Massachusetts.


DEAL STATS #
Overall 11 of 11
Sector (Medical Products) 2 of 2
Type (Divestiture) 11 of 11
State (Connecticut) 1 of 1
Country (United States) 11 of 11
Year (2022) 1 of 1
Size (of disclosed) 1 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-07-26 BioLegend

San Diego, California, United States

BioLegend is a provider of life science antibodies and reagents for biomedical research. BioLegend is based in San Diego, California.

Buy $5.3B